-
1
-
-
50949115126
-
Atrial remodeling and atrial fibrillation: Mechanisms and implications
-
Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008;1:62-73.
-
(2008)
Circ Arrhythm Electrophysiol
, vol.1
, pp. 62-73
-
-
Nattel, S.1
Burstein, B.2
Dobrev, D.3
-
2
-
-
84864477617
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
Authors/Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Böhm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
Jaarsma, T.11
Køber, L.12
Lip, G.Y.13
Maggioni, A.P.14
Parkhomenko, A.15
Pieske, B.M.16
Popescu, B.A.17
Rønnevik, P.K.18
Rutten, F.H.19
Schwitter, J.20
Seferovic, P.21
Stepinska, J.22
Trindade, P.T.23
Voors, A.A.24
Zannad, F.25
Zeiher, A.26
Bax, J.J.27
Baumgartner, H.28
Ceconi, C.29
Dean, V.30
Deaton, C.31
Fagard, R.32
Funck-Brentano, C.33
Hasdai, D.34
Hoes, A.35
Kirchhof, P.36
Knuuti, J.37
Kolh, P.38
McDonagh, T.39
Moulin, C.40
Popescu, B.A.41
Reiner, Z.42
Sechtem, U.43
Sirnes, P.A.44
Tendera, M.45
Torbicki, A.46
Vahanian, A.47
Windecker, S.48
Reviewers, D.49
McDonagh, T.50
Sechtem, U.51
Bonet, L.A.52
Avraamides, P.53
Ben Lamin, H.A.54
Brignole, M.55
Coca, A.56
Cowburn, P.57
Dargie, H.58
Elliott, P.59
Flachskampf, F.A.60
Guida, G.F.61
Hardman, S.62
Iung, B.63
Merkely, B.64
Mueller, C.65
Nanas, J.N.66
Nielsen, O.W.67
Orn, S.68
Parissis, J.T.69
Ponikowski, P.70
more..
-
3
-
-
84859357588
-
Novel Molecular Targets for Atrial Fibrillation Therapy
-
Dobrev D, Carlsson L, Nattel S. Novel molecular targets for atrial fibrillation therapy. Nat Rev Drug Discov 2012;11:275-291.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 275-291
-
-
Dobrev, D.1
Carlsson, L.2
Nattel, S.3
-
5
-
-
53049104215
-
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome
-
Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 2008;19:1289-1293.
-
(2008)
J Cardiovasc Electrophysiol
, vol.19
, pp. 1289-1293
-
-
Moss, A.J.1
Zareba, W.2
Schwarz, K.Q.3
Rosero, S.4
McNitt, S.5
Robinson, J.L.6
-
6
-
-
4344577023
-
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties
-
Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Cordeiro JM, Thomas G. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004;110: 904-910.
-
(2004)
Circulation
, vol.110
, pp. 904-910
-
-
Antzelevitch, C.1
Belardinelli, L.2
Zygmunt, A.C.3
Burashnikov, A.4
Di Diego, J.M.5
Fish, J.M.6
Cordeiro, J.M.7
Thomas, G.8
-
7
-
-
35148850168
-
Effect of ranola-zine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: Metabolic Efficiency with Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial
-
Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, Molhoek P, Verheugt FW, Gersh BJ, McCabe CH, Braunwald E. Effect of ranola-zine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2007;116: 1647-1652.
-
(2007)
Circulation
, vol.116
, pp. 1647-1652
-
-
Scirica, B.M.1
Morrow, D.A.2
Hod, H.3
Murphy, S.A.4
Belardinelli, L.5
Hedgepeth, C.M.6
Molhoek, P.7
Verheugt, F.W.8
Gersh, B.J.9
McCabe, C.H.10
Braunwald, E.11
-
8
-
-
34748873780
-
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine
-
Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 2007;116:1449-1457.
-
(2007)
Circulation
, vol.116
, pp. 1449-1457
-
-
Burashnikov, A.1
Di Diego, J.M.2
Zygmunt, A.C.3
Belardinelli, L.4
Antzelevitch, C.5
-
9
-
-
46349111138
-
Antiarrhythmic effects of rano-lazine in canine pulmonary vein sleeve preparations
-
Sicouri S, Glass A, Belardinelli L, Antzelevitch C. Antiarrhythmic effects of rano-lazine in canine pulmonary vein sleeve preparations. Heart Rhythm 2008;5: 1019-1026.
-
(2008)
Heart Rhythm
, vol.5
, pp. 1019-1026
-
-
Sicouri, S.1
Glass, A.2
Belardinelli, L.3
Antzelevitch, C.4
-
10
-
-
67649795769
-
Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart
-
Kumar K, Nearing BD, Carvas M, Nascimento BC, Acar M, Belardinelli L, Verrier RL. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. J Cardiovasc Elec-trophysiol 2009;20:796-802.
-
(2009)
J Cardiovasc Elec-trophysiol
, vol.20
, pp. 796-802
-
-
Kumar, K.1
Nearing, B.D.2
Carvas, M.3
Nascimento, B.C.4
Acar, M.5
Belardinelli, L.6
Verrier, R.L.7
-
11
-
-
77952165183
-
Altered Na(+) currents in atrial fibrillation: Effects of ranolazine on arrhythmias and contractility in human atrial myocardium
-
Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schondube FA, Hasenfuss G, Belardinelli L, Maier LS. Altered Na(+) currents in atrial fibrillation: effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 2010;55:2330-2342.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2330-2342
-
-
Sossalla, S.1
Kallmeyer, B.2
Wagner, S.3
Mazur, M.4
Maurer, U.5
Toischer, K.6
Schmitto, J.D.7
Seipelt, R.8
Schondube, F.A.9
Hasenfuss, G.10
Belardinelli, L.11
Maier, L.S.12
-
12
-
-
80051802104
-
Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting
-
Miles RH, Passman R, Murdock DK. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2011;108:673-676.
-
(2011)
Am J Cardiol
, vol.108
, pp. 673-676
-
-
Miles, R.H.1
Passman, R.2
Murdock, D.K.3
-
13
-
-
55849135767
-
The effect of rano-lazine on maintaining sinus rhythm in patients with resistant atrial fibrillation
-
Murdock DK, Overton N, Kersten M, Kaliebe J, Devecchi F. The effect of rano-lazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. Indian Pacing Electrophysiol J 2008;8:175-181.
-
(2008)
Indian Pacing Electrophysiol J
, vol.8
, pp. 175-181
-
-
Murdock, D.K.1
Overton, N.2
Kersten, M.3
Kaliebe, J.4
Devecchi, F.5
-
14
-
-
80053272921
-
A new mechanism preventing proarrhythmia in chronic heart failure: Rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure
-
Frommeyer G, Milberg P, Witte P, Stypmann J, Koopmann M, Lücke M, Osada N, Breithardt G, Fehr M, Eckardt L. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure. Eur J Heart Fail 2011;13:1060-1069.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 1060-1069
-
-
Frommeyer, G.1
Milberg, P.2
Witte, P.3
Stypmann, J.4
Koopmann, M.5
Lücke, M.6
Osada, N.7
Breithardt, G.8
Fehr, M.9
Eckardt, L.10
-
15
-
-
77955454250
-
Increased inducible nitric oxide synthase and arginase II expression in heart failure: No net nitrite/nitrate production and protein S-nitrosylation
-
Heusch P, Aker S, Boengler K, Deindl E, van de Sand A, Klein K, Rassaf T, Konietzka I, Sewell A, Menazza S, Canton M, Heusch G, Di Lisa F, Schulz R. Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation. Am J Physiol Heart Circ Physiol 2010;299:H446-H453.
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.299
-
-
Heusch, P.1
Aker, S.2
Boengler, K.3
Deindl, E.4
Van De Sand, A.5
Klein, K.6
Rassaf, T.7
Konietzka, I.8
Sewell, A.9
Menazza, S.10
Canton, M.11
Heusch, G.12
Di Lisa, F.13
Schulz, R.14
-
16
-
-
34249090724
-
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome
-
Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. J Cardiovasc Electrophysiol 2007;18: 658-664.
-
(2007)
J Cardiovasc Electrophysiol
, vol.18
, pp. 658-664
-
-
Milberg, P.1
Tegelkamp, R.2
Osada, N.3
Schimpf, R.4
Wolpert, C.5
Breithardt, G.6
Borggrefe, M.7
Eckardt, L.8
-
17
-
-
0035141956
-
Verapamil prevents stretch-induced shortening of atrial effective refractory period in Langendorff-perfused rabbit heart
-
Zarse M, Stellbrink C, Athanatou E, Robert J, Schotten U, Hanrath P. Verapamil prevents stretch-induced shortening of atrial effective refractory period in Langendorff-perfused rabbit heart. J Cardiovasc Electrophysiol 2001;12:85-92.
-
(2001)
J Cardiovasc Electrophysiol
, vol.12
, pp. 85-92
-
-
Zarse, M.1
Stellbrink, C.2
Athanatou, E.3
Robert, J.4
Schotten, U.5
Hanrath, P.6
-
18
-
-
79951612690
-
Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations
-
Sicouri S, Gianetti B, Zygmunt AC, Cordeiro JM, Antzelevitch C. Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. J Am Coll Cardiol 2011;57:986-993.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 986-993
-
-
Sicouri, S.1
Gianetti, B.2
Zygmunt, A.C.3
Cordeiro, J.M.4
Antzelevitch, C.5
-
19
-
-
0344404215
-
Postrepolarization refractoriness versus conduction slowing caused by class i antiarrhythmic drugs: Antiarrhythmic and proar-rhythmic effects
-
Kirchhof PF, Fabritz CL, Franz MR. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proar-rhythmic effects. Circulation 1998;97:2567-2574.
-
(1998)
Circulation
, vol.97
, pp. 2567-2574
-
-
Kirchhof, P.F.1
Fabritz, C.L.2
Franz, M.R.3
-
20
-
-
0030804511
-
Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart
-
Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997;96:1686-1695.
-
(1997)
Circulation
, vol.96
, pp. 1686-1695
-
-
Ravelli, F.1
Allessie, M.2
-
21
-
-
70449119097
-
Use-dependent block of cardiac late Na(+) current by ranolazine
-
Rajamani S, El-Bizri N, Shryock JC, Makielski JC, Belardinelli L. Use-dependent block of cardiac late Na(+) current by ranolazine. Heart Rhythm 2009;6: 1625-1631.
-
(2009)
Heart Rhythm
, vol.6
, pp. 1625-1631
-
-
Rajamani, S.1
El-Bizri, N.2
Shryock, J.C.3
Makielski, J.C.4
Belardinelli, L.5
-
22
-
-
0037381289
-
Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation
-
Kirchhof P, Degen H, Franz MR, Eckardt L, Fabritz L, Milberg P, Laer S, Neumann J, Breithardt G, Haverkamp W. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation. J Pharmacol Exp Ther 2003; 305:257-263.
-
(2003)
J Pharmacol Exp Ther
, vol.305
, pp. 257-263
-
-
Kirchhof, P.1
Degen, H.2
Franz, M.R.3
Eckardt, L.4
Fabritz, L.5
Milberg, P.6
Laer, S.7
Neumann, J.8
Breithardt, G.9
Haverkamp, W.10
-
23
-
-
41149174179
-
Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation
-
Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation. Ann NY Acad Sci 2008;1123:105-112.
-
(2008)
Ann NY Acad Sci
, vol.1123
, pp. 105-112
-
-
Burashnikov, A.1
Di Diego, J.M.2
Zygmunt, A.C.3
Belardinelli, L.4
Antzelevitch, C.5
-
24
-
-
84862253884
-
Rate-dependent Effects of Vernakalant in the Isolated Non-remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel: Comparison with Ranolazine and Dl-sotalol
-
Burashnikov A, Pourrier M, Gibson JK, Lynch JJ, Antzelevitch C. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol. Circ Arrhythm Electrophysiol 2012;5:400-408.
-
(2012)
Circ Arrhythm Electrophysiol
, vol.5
, pp. 400-408
-
-
Burashnikov, A.1
Pourrier, M.2
Gibson, J.K.3
Lynch, J.J.4
Antzelevitch, C.5
-
25
-
-
84857640089
-
Pathophysiology of the cardiac late Na current and its potential as a drug target
-
Moreno JD, Clancy CE. Pathophysiology of the cardiac late Na current and its potential as a drug target. J Mol Cell Cardiol 2012;52:608-619.
-
(2012)
J Mol Cell Cardiol
, vol.52
, pp. 608-619
-
-
Moreno, J.D.1
Clancy, C.E.2
-
26
-
-
0034612363
-
Effects of experimental heart failure on atrial cellular and ionic electrophysiology
-
Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000; 101:2631-2638.
-
(2000)
Circulation
, vol.101
, pp. 2631-2638
-
-
Li, D.1
Melnyk, P.2
Feng, J.3
Wang, Z.4
Petrecca, K.5
Shrier, A.6
Nattel, S.7
-
27
-
-
0038689293
-
Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation
-
Verheule S, Wilson E, Everett Tt, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 2003;107:2615-2622.
-
(2003)
Circulation
, vol.107
, pp. 2615-2622
-
-
Verheule, S.1
Wilson, E.2
Tt, E.3
Shanbhag, S.4
Golden, C.5
Olgin, J.6
-
28
-
-
79961166764
-
Atrial-selective sodium channel block by dronedarone: Sufficient to terminate atrial fibrillation?
-
Ehrlich JR, Dobrev D. Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation? Naunyn Schmiedebergs Arch Pharmacol 2011; 384:109-114.
-
(2011)
Naunyn Schmiedebergs Arch Pharmacol
, vol.384
, pp. 109-114
-
-
Ehrlich, J.R.1
Dobrev, D.2
-
29
-
-
74149094943
-
Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass
-
Hilliard FA, Steele DS, Laver D, Yang Z, Le Marchand SJ, Chopra N, Piston DW, Huke S, Knollmann BC. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol 2010;48:293-301.
-
(2010)
J Mol Cell Cardiol
, vol.48
, pp. 293-301
-
-
Hilliard, F.A.1
Steele, D.S.2
Laver, D.3
Yang, Z.4
Le Marchand, S.J.5
Chopra, N.6
Piston, D.W.7
Huke, S.8
Knollmann, B.C.9
-
30
-
-
79960985606
-
Recent advances in the molecular pathophysiology of atrial fibrillation
-
Wakili R, Voigt N, Kaab S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011;121:2955-2968.
-
(2011)
J Clin Invest
, vol.121
, pp. 2955-2968
-
-
Wakili, R.1
Voigt, N.2
Kaab, S.3
Dobrev, D.4
Nattel, S.5
-
31
-
-
45849133911
-
Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation
-
Sood S, Chelu MG, van Oort RJ, Skapura D, Santonastasi M, Dobrev D, Wehrens XH. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 2008;5:1047-1054.
-
(2008)
Heart Rhythm
, vol.5
, pp. 1047-1054
-
-
Sood, S.1
Chelu, M.G.2
Van Oort, R.J.3
Skapura, D.4
Santonastasi, M.5
Dobrev, D.6
Wehrens, X.H.7
-
32
-
-
84856693079
-
Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice
-
Li N, Wang T, Wang W, Cutler MJ, Wang Q, Voigt N, Rosenbaum DS, Dobrev D, Wehrens XH. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ Res 2012;110: 465-470.
-
(2012)
Circ Res
, vol.110
, pp. 465-470
-
-
Li, N.1
Wang, T.2
Wang, W.3
Cutler, M.J.4
Wang, Q.5
Voigt, N.6
Rosenbaum, D.S.7
Dobrev, D.8
Wehrens, X.H.9
-
33
-
-
20244384717
-
Defective cardiac ryanodine receptor regulation during atrial fibrillation
-
Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-2032.
-
(2005)
Circulation
, vol.111
, pp. 2025-2032
-
-
Vest, J.A.1
Wehrens, X.H.2
Reiken, S.R.3
Lehnart, S.E.4
Dobrev, D.5
Chandra, P.6
Danilo, P.7
Ravens, U.8
Rosen, M.R.9
Marks, A.R.10
-
34
-
-
4544288714
-
Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes
-
Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez Font E, Aris A, Cinca J. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110:1358-1363.
-
(2004)
Circulation
, vol.110
, pp. 1358-1363
-
-
Hove-Madsen, L.1
Llach, A.2
Bayes-Genis, A.3
Roura, S.4
Rodriguez Font, E.5
Aris, A.6
Cinca, J.7
-
35
-
-
80055004672
-
Human Atrial Action Potential and Ca2+ Model: Sinus Rhythm and Chronic Atrial Fibrillation
-
Grandi E, Pandit SV, Voigt N, Workman AJ, Dobrev D, Jalife J, Bers DM. Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation. Circ Res 2011;109:1055-1066.
-
(2011)
Circ Res
, vol.109
-
-
Grandi, E.1
Pandit, S.V.2
Voigt, N.3
Workman, A.J.4
Dobrev, D.5
Jalife, J.6
Bers, D.M.7
-
36
-
-
84860338741
-
Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients with Chronic Atrial Fibrillation
-
Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XH, Dobrev D. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 2012; 125:2059-2070.
-
(2012)
Circulation
, vol.125
-
-
Voigt, N.1
Li, N.2
Wang, Q.3
Wang, W.4
Trafford, A.W.5
Abu-Taha, I.6
Sun, Q.7
Wieland, T.8
Ravens, U.9
Nattel, S.10
Wehrens, X.H.11
Dobrev, D.12
-
37
-
-
84856784190
-
Proarrhythmia in a non-failing murine model of cardiac-specific Na +/Ca2+ exchanger overexpression: Whole heart and cellular mechanisms
-
Pott C, Muszynski A, Ruhe M, Bögeholz N, Schulte JS, Milberg P, Mönnig G, Fabritz L, Goldhaber JI, Breithardt G, Schmitz W, Philipson KD, Eckardt L, Kirchhof P, Muller FU. Proarrhythmia in a non-failing murine model of cardiac-specific Na +/Ca2+ exchanger overexpression: whole heart and cellular mechanisms. Basic Res Cardiol 2012;107:247.
-
(2012)
Basic Res Cardiol
, vol.107
, pp. 247
-
-
Pott, C.1
Muszynski, A.2
Ruhe, M.3
Bögeholz, N.4
Schulte, J.S.5
Milberg, P.6
Mönnig, G.7
Fabritz, L.8
Goldhaber, J.I.9
Breithardt, G.10
Schmitz, W.11
Philipson, K.D.12
Eckardt, L.13
Kirchhof, P.14
Muller, F.U.15
-
38
-
-
84861330609
-
Ranolazine Stabilizes Cardiac Ryanodine Receptors: A Novel Mechanism for the Suppression of Early Afterdepolarization and Torsades de Pointes in Long QT Type 2
-
Parikh A, Mantravadi R, Kozhevnikov D, Roche MA, Ye Y, Owen LJ, Puglisi JL, Abramson JJ, Salama G. Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2. Heart Rhythm 2012;9:953-960.
-
(2012)
Heart Rhythm
, vol.9
, pp. 953-960
-
-
Parikh, A.1
Mantravadi, R.2
Kozhevnikov, D.3
Roche, M.A.4
Ye, Y.5
Owen, L.J.6
Puglisi, J.L.7
Abramson, J.J.8
Salama, G.9
-
39
-
-
84861867021
-
Ranolazine Decreases Mechanosensitivity of the Voltage-gated Sodium Ion Channel Nav1.5: A Novel Mechanism of Drug Action
-
Beyder A, Strege PR, Reyes S, Bernard CE, Terzic A, Makielski J, Ackerman MJ, Farrugia G. Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Nav1.5: a novel mechanism of drug action. Circulation 2012; 125:2698-2706.
-
(2012)
Circulation
, vol.125
-
-
Beyder, A.1
Strege, P.R.2
Reyes, S.3
Bernard, C.E.4
Terzic, A.5
Makielski, J.6
Ackerman, M.J.7
Farrugia, G.8
-
40
-
-
84862776882
-
Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium Sensitivity
-
Lovelock JD, Monasky MM, Jeong EM, Lardin HA, Liu H, Patel BG, Taglieri DM, Gu L, Kumar P, Pokhrel N, Zeng D, Belardinelli L, Sorescu D, Solaro RJ, Dudley SC Jr. Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. Circ Res 2012;110:841-850.
-
(2012)
Circ Res
, vol.110
, pp. 841-850
-
-
Lovelock, J.D.1
Monasky, M.M.2
Jeong, E.M.3
Lardin, H.A.4
Liu, H.5
Patel, B.G.6
Taglieri, D.M.7
Gu, L.8
Kumar, P.9
Pokhrel, N.10
Zeng, D.11
Belardinelli, L.12
Sorescu, D.13
Solaro, R.J.14
Dudley, Jr.S.C.15
-
41
-
-
84863723103
-
Myofilament Ca Sensitization Increases Cytosolic Ca Binding Affinity Alters Intracellular Ca Homeostasis and Causes Pause-dependent Ca Triggered Arrhythmia
-
Schober T, Huke S, Venkataraman R, Gryshchenko O, Kryshtal D, Hwang HS, Baudenbacher FJ, Knollmann BC. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca triggered arrhythmia. Circ Res 2012;111:170-179.
-
(2012)
Circ Res
, vol.111
, pp. 170-179
-
-
Schober, T.1
Huke, S.2
Venkataraman, R.3
Gryshchenko, O.4
Kryshtal, D.5
Hwang, H.S.6
Baudenbacher, F.J.7
Knollmann, B.C.8
-
42
-
-
84856134386
-
Targeting myocardial substrate metabolism in heart failure: Potential for new therapies
-
Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail 2012;14:120-129.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 120-129
-
-
Ardehali, H.1
Sabbah, H.N.2
Burke, M.A.3
Sarma, S.4
Liu, P.P.5
Cleland, J.G.6
Maggioni, A.7
Fonarow, G.C.8
Abel, E.D.9
Campia, U.10
Gheorghiade, M.11
-
43
-
-
84855163167
-
Dronedarone in high-risk permanent atrial fibrillation
-
Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum A, Blomstroem P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacretaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbuchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsanyi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH, Investigators P. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011;365:2268-2276.
-
(2011)
N Engl J Med
, vol.365
, pp. 2268-2276
-
-
Connolly, S.J.1
Camm, A.J.2
Halperin, J.L.3
Joyner, C.4
Alings, M.5
Amerena, J.6
Atar, D.7
Avezum, A.8
Blomstroem, P.9
Borggrefe, M.10
Budaj, A.11
Chen, S.A.12
Ching, C.K.13
Commerford, P.14
Dans, A.15
Davy, J.M.16
Delacretaz, E.17
Di Pasquale, G.18
Diaz, R.19
Dorian, P.20
Flaker, G.21
Golitsyn, S.22
Gonzalez-Hermosillo, A.23
Granger, C.B.24
Heidbuchel, H.25
Kautzner, J.26
Kim, J.S.27
Lanas, F.28
Lewis, B.S.29
Merino, J.L.30
Morillo, C.31
Murin, J.32
Narasimhan, C.33
Paolasso, E.34
Parkhomenko, A.35
Peters, N.S.36
Sim, K.H.37
Stiles, M.K.38
Tanomsup, S.39
Toivonen, L.40
Tomcsanyi, J.41
Torp-Pedersen, C.42
Tse, H.F.43
Vardas, P.44
Vinereanu, D.45
Xavier, D.46
Zhu, J.47
Zhu, J.R.48
Baret-Cormel, L.49
Weinling, E.50
Staiger, C.51
Yusuf, S.52
Chrolavicius, S.53
Afzal, R.54
Hohnloser, S.H.55
more..
|